-
How an experimental gene editing treatment helped a desperately ill baby
A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made just for him.
-
Daughter says mom ‘gave me life twice' with kidney donation as pair graduate nursing school together
A mother and daughter are celebrating yet another milestone, having navigated the challenges of a kidney transplant and nursing school side by side.
-
5 things to know about Dr. Marty Makary
Here are five things to know about surgeon and author Dr. Marty Makary.
-
Wisconsin couple sues Walgreens, claims son died from rising cost of asthma meds
A Wisconsin couple is suing Walgreens and a pharmacy benefits management company, alleging that their son died because he couldn’t afford a sudden $500 spike in his asthma medication.
-
Trump's China tariffs likely to drive up drug prices, spur shortages, experts say
China is playing an increasing role in manufacturing active pharmaceutical ingredients.
-
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC News reported.
-
Do dogs need coats? How to protect pets from the cold, according to a vet
Here are hazards that pet owners should watch out for in winter weather, from antifreeze poisoning to frozen bodies of water, according to veterinary medicine expert Dr. Steven Marks.
-
Tennessee woman accused of selling fake weight loss drugs as counterfeit concerns grow
The woman was accused of selling counterfeit versions of popular weight loss drugs including Ozempic and Wegovy. Experts say fakes have exploded in the U.S.
-
Trump's tariffs could raise the cost of generic drugs in the U.S.
The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, policy experts say.
-
Clinical trials sparking hope for Alzheimer's patients: ‘Holding my own'
A clinical trial is testing whether an existing drug could benefit patients with Alzheimer’s disease, in hopes of making symptom-improving medication more accessible for people experiencing mild cognitive impairment.
-
Conjoined twins return home after successful separation surgery at CHOP
Amari and Javar, conjoined twins, have returned home after undergoing an intensive separation surgery at the Children’s Hospital of Philadelphia. NBC10’s Frances Wang shares the family’s story that ended in joy.
-
Conjoined twins successfully separated at CHOP
Amari and Javar Ruffin were separated at Children’s Hospital of Philadelphia last month. The twins had shared the lowest part of their sternum, diaphragm, abdominal wall and liver.
-
CHOP surgeons successfully separate conjoined twin boys after 8-hour surgery
After spending nearly a year at Children’s Hospital of Philadelphia, conjoined twins Amari and Javar Ruffin were successfully separated.
-
Remember the prescription drug shortages from last year? The problem hasn't gone away
Forty years after the Hatch-Waxman Act created a market for affordable generic versions of prescription medications, it is struggling with persistent shortages.
-
American scientists win Nobel Prize for the discovering of microRNA
Their surprising discovery revealed an entirely new dimension to gene regulation as the microRNAs are proving to be fundamentally important for how organisms develop and function.
-
Maker of Ozempic and Wegovy faces grilling over high cost of weight loss drugs
Is Novo Nordisk helping Americans save taxpayer money or ripping them off? The company’s CEO is scheduled to testify Tuesday on Capitol Hill.
-
Eli Lilly's weight loss drug slashes the risk of developing diabetes in long-term trial
The late-stage trial on tirzepatide also found that patients experienced sustained weight loss over the roughly three-year treatment period.
-
US challenges ‘bogus' patents on Ozempic and other drugs in effort to spur competition
Federal regulators on Tuesday sent warning letters to several drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other respiratory conditions.
-
Biden sees a $35 price cap for insulin as a pivotal campaign issue. It's not that clear-cut
President Joe Biden often overstates what people who are eligible for the price cap for insulin paid previously.
-
3 signs it's time to break up with your doctor—'your health is one of your most important assets,' physician says
A doctor who was once a good fit might not always meet the needs you have now. Here are some signs that it’s time to find a new one.